Table 2 Characteristics of patients with bacteraemia due to urinary tract infections caused by ESBL-producing Enterobacteriaceae
CBP, N = 12 | non-CBPBL, N = 7 | OR* (95% CI) | P* | |
|---|---|---|---|---|
Age, mean [±SD] | 76.7 [±7.2] | 72.9 [±18.1] | NA | 0.9 |
Male sex | 2 (16.7) | 3 (42.9) | 0.3 (0.02–3.5) | 0.31 |
Nursing home resident | 6 (50) | 1 (14.3) | 5.5 (0.4–320.4) | 0.17 |
Hospital-acquired | 5 (41.7) | 0 (0) | NA | 0.11 |
Community-acquired | 7 (58.3) | 7 (100) | NA | 0.11 |
Non-healthcare-associated | 2 (16.7) | 3 (42.8) | 0.3 (0.02–3.5) | 0.31 |
Antibiotics use within the previous 3 months | 4 (40)a | 4 (57) | 1.1 (0.1–11.6) | 1.0 |
Underlying diseases related to the urinary tract | 2 (16.7) | 3 (42.9) | 0.3 (0.02–3.5) | 0.31 |
History of UTI | 8 (66.7) | 2 (28.6) | 4.6 (0.5–69.2) | 0.17 |
Urinary catheter use | 4 (33.3) | 1 (14.3) | 2.8 (0.2–171.8) | 0.6 |
Previous hospital days, mean [SD] | 90 [±156.6] | 0 | NA | 0.06 |
Any immunosuppressive conditionb | 9 (75) | 4 (57) | 2.2 (0.2–24.7) | 0.62 |
Diabetes mellitus | 3 (25) | 1 (14.3) | 1.9 (0.1–122.1) | 1.0 |
Malignancy | 1 (8.3) | 4 (57.1) | 0.1 (0.001–1.2) | 0.04 |
Pitt bacteraemia score, median [IQR] | 4 [2–5] | 3 [2–4] | NA | 0.57 |
Causative bacteria species | ||||
Escherichia coli | 11 (91.7) | 6 (85.7) | 1.8 (0.02–156.6) | 1.0 |
Klebsiella pneumoniae | 1 (8.3) | 1 (14.3) | 0.6 (0.006–49.9) | 1.0 |
Use of CBP as definitive therapy | 9 (75) | 2 (29) | 21.1 (1.4–1395.7) | 0.01 |